Amide linked ep4 agonist-bisphosphonate compounds and uses thereof
A compound, the technology of sodium hydrogen phosphonate, applied in the compound of elements of Group 5/15 of the periodic table, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0171] Synthesis of C3-conjugated compound 1
[0172]
[0173] a) 4-(carboxymethyl)benzoic acid (1.6 equiv), DCC (1.5 equiv), DMAP (0.02 equiv), pyridine (2.4 equiv), CH 2 Cl 2 , room temperature, 2h; b) N-hydroxysuccinimide (2.7 equivalents), EDCl (2.7 equivalents), DMF, room temperature, 7h, the yield after the completion of the two-step reaction was 80%; c) alendronic acid (4 equivalents), triethylamine (11.3 equivalents), DMF / H 2 O(v / v)2:1, room temperature, 10min, 80%.
[0174] 2,5-Dioxypyrrolidinyl-1-yl 4-(2-(((R,E)-4-((R)-1-(7-ethoxy-7-oxoheptyl)- 5-oxopyrrolidinyl-2-yl)-1,1-difluoro-1-phenylbut-3-en-2-yl)oxy)-2-oxoethyl)benzoate ( 9)(2,5-Dioxopyrrolidin-1-yl4-(2-(((R,E)-4-((R)-1-(7-ethoxy-7-oxoheptyl)-5-oxopyrrolidin-2-yl )-1,1-difluoro-1-phenylbut-3-en-2-yl)oxy)-2-oxoethyl)benzoate(9))
[0175] EP4-ester 7 (0.200g, 0.47mmol, 1 equiv) dissolved in dry CH 2 Cl 2 (2.4mL), then 4-(carboxymethyl)benzoic acid (0.134g, 0.75mmol, 1.6eq), DMAP (0.001g, 0.01mmol, 0....
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


